Search

everythinglearnresearchcommunity

for

Search:↓

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Methotrexate plus prednisolone had the fewest serious side effects.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Minoxidil is compatible with some excipients but not with others, affecting formulation choices.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

Clofazimine effectively treated ashy dermatosis in a patient.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Combination therapy may be more effective for difficult-to-treat scalp conditions.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Scalp condition healed with prednisone and tacrolimus.

Azole antifungals can cause skin reactions like EAC, requiring careful management.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

EK significantly improved wound healing and reduced infection in burn wounds.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Some patients who had a severe drug reaction developed long-term hair loss.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Ruxolitinib can cause a delayed skin reaction on the nose.